{"disease":{"id":"bulging","name":"bulging"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02398188","title":"Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":793,"lead_sponsor_name":"Evofem Inc.","has_results":true},{"nct_id":"NCT03433430","title":"Multi-Center Pilot Study of truSculpt Device","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Cutera Inc.","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}